Watchlist Manager

Watchlist

Price: 1.75 CNY -0.57%

Market Cap: ¥24.2B

	Kangmei Pharmaceutical Co Ltd SSE:600518	CN
A	Amazon.com Inc MIL:AMZN	US
	Rupa & Company Ltd NSE:RUPA	IN
C	China Smarter Energy Group Holdings Ltd HKEX:1004	HK
	Ernest Borel Holdings Ltd HKEX:1856	HK
P	PNC Infratech Ltd NSE:PNCINFRA	IN
	TJX Companies Inc NYSE:TJX	US
G	Gentex Corp SWB:GTX	US
	Cimbeton Hazirbeton ve Prefabrik Yapi Elemanlari Sanayi ve Ticaret AS IST:CMBTN.E	TR

Income Statement

Currency: CNY

	Dec-2004	Mar-2005	Jun-2005	Sep-2005	Dec-2005	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	13	0	0	0	13	0	0	0	22	0	0	0	39	0	0	0	79	0	0	0	104	0	0	0	140	0	0	0	269	0	0	0	360	0	0	0	406	0	0	0	491	0	0	0	589	0	0	0	871	0	0	329	1 218	686	1 127	1 294	1 838	2 001	2 149	2 233	2 249	2 105	2 170	2 142	2 164	2 277	1 960	1 410	1 022	527	193	194	79	79	80	80	56	56	56	55	21	20	0	0
Revenue	553 N/A	577 +4%	580 +1%	580 0%	585 +1%	606 +4%	643 +6%	731 +14%	826 +13%	901 +9%	1 079 +20%	1 178 +9%	1 294 +10%	1 394 +8%	1 521 +9%	1 667 +10%	1 727 +4%	1 991 +15%	2 098 +5%	2 168 +3%	2 377 +10%	2 484 +5%	2 656 +7%	2 937 +11%	3 309 +13%	4 000 +21%	4 628 +16%	5 278 +14%	6 081 +15%	7 241 +19%	8 401 +16%	9 704 +16%	11 165 +15%	11 936 +7%	12 158 +2%	12 746 +5%	13 359 +5%	14 233 +7%	15 015 +5%	15 459 +3%	15 949 +3%	16 755 +5%	17 252 +3%	17 827 +3%	18 067 +1%	18 950 +5%	20 205 +7%	21 068 +4%	21 642 +3%	22 911 +6%	23 701 +3%	24 701 +4%	17 579 -29%	15 317 -13%	13 924 -9%	12 559 -10%	17 065 +36%	17 074 +0%	15 590 -9%	12 918 -17%	11 446 -11%	7 714 -33%	5 830 -24%	5 070 -13%	5 412 +7%	5 330 -2%	4 965 -7%	4 526 -9%	4 153 -8%	3 999 -4%	3 862 -3%	3 788 -2%	4 180 +10%	4 390 +5%	4 778 +9%	4 992 +4%	4 874 -2%	4 931 +1%	4 971 +1%	5 213 +5%	5 189 0%	5 287 +2%	5 292 +0%	5 275 0%
Gross Profit
Cost of Revenue	(385)	(398)	(397)	(398)	(404)	(419)	(443)	(512)	(588)	(652)	(801)	(876)	(961)	(1 031)	(1 117)	(1 224)	(1 266)	(1 451)	(1 517)	(1 537)	(1 590)	(1 591)	(1 674)	(1 846)	(2 119)	(2 639)	(3 142)	(3 620)	(4 272)	(5 174)	(6 118)	(7 244)	(8 379)	(8 964)	(9 057)	(9 441)	(9 899)	(10 637)	(11 249)	(11 536)	(11 807)	(12 446)	(12 741)	(13 103)	(12 999)	(13 756)	(14 624)	(15 171)	(15 276)	(16 212)	(16 719)	(17 291)	(10 887)	(9 535)	(8 597)	(7 753)	(11 727)	(11 892)	(10 604)	(8 180)	(10 597)	(7 477)	(6 559)	(6 931)	(25 725)	(5 349)	(4 994)	(4 432)	(4 620)	(4 067)	(3 935)	(3 850)	(3 852)	(3 930)	(4 235)	(4 460)	(3 791)	(3 811)	(3 901)	(4 138)	(4 536)	(4 526)	(4 468)	(4 372)
Gross Profit	168 N/A	179 +6%	183 +2%	182 -1%	180 -1%	187 +4%	200 +7%	219 +10%	238 +9%	249 +5%	278 +12%	301 +8%	333 +11%	362 +9%	404 +11%	442 +10%	461 +4%	539 +17%	580 +8%	630 +9%	787 +25%	894 +14%	982 +10%	1 091 +11%	1 190 +9%	1 361 +14%	1 486 +9%	1 658 +12%	1 808 +9%	2 067 +14%	2 283 +10%	2 460 +8%	2 786 +13%	2 972 +7%	3 101 +4%	3 305 +7%	3 460 +5%	3 596 +4%	3 766 +5%	3 922 +4%	4 142 +6%	4 309 +4%	4 511 +5%	4 724 +5%	5 068 +7%	5 194 +2%	5 582 +7%	5 896 +6%	6 366 +8%	6 699 +5%	6 982 +4%	7 410 +6%	6 692 -10%	5 782 -14%	5 327 -8%	4 806 -10%	5 338 +11%	5 182 -3%	4 987 -4%	4 738 -5%	849 -82%	237 -72%	(730) N/A	(1 862) -155%	(20 313) -991%	(19) +100%	(30) -59%	94 N/A	(468) N/A	(68) +85%	(73) -7%	(62) +15%	329 N/A	461 +40%	544 +18%	533 -2%	1 083 +103%	1 120 +3%	1 070 -4%	1 076 +1%	653 -39%	761 +17%	824 +8%	903 +10%
Operating Income
Operating Expenses	(53)	(57)	(61)	(61)	(61)	(62)	(63)	(68)	(71)	(73)	(79)	(85)	(93)	(102)	(108)	(116)	(129)	(135)	(147)	(166)	(189)	(219)	(257)	(288)	(337)	(377)	(412)	(463)	(513)	(573)	(633)	(705)	(825)	(806)	(831)	(874)	(982)	(953)	(1 003)	(1 014)	(1 101)	(1 097)	(1 155)	(1 216)	(1 499)	(1 360)	(1 460)	(1 515)	(1 787)	(1 748)	(1 819)	(1 955)	(2 772)	(2 738)	(2 889)	(3 113)	(2 850)	(2 748)	(2 813)	(2 740)	(2 679)	(3 273)	(3 193)	(2 981)	(3 151)	(25 054)	(24 733)	(24 548)	(3 553)	10 974	11 020	11 013	(1 339)	(2 158)	(2 223)	(2 160)	(911)	(1 036)	(905)	(955)	(1 041)	(819)	(859)	(883)
Selling, General & Administrative	(53)	(57)	(62)	(61)	(60)	(63)	(63)	(68)	(71)	(73)	(79)	(84)	(92)	(100)	(105)	(114)	(127)	(133)	(144)	(163)	(185)	(216)	(255)	(288)	(332)	(370)	(406)	(456)	(503)	(565)	(621)	(686)	(667)	(779)	(809)	(860)	(771)	(944)	(989)	(992)	(865)	(1 065)	(1 107)	(1 163)	(1 212)	(1 250)	(1 356)	(1 424)	(1 388)	(1 691)	(1 769)	(1 867)	(2 344)	(2 551)	(2 728)	(2 957)	(2 354)	(2 521)	(2 587)	(2 539)	(2 074)	(2 073)	(1 970)	(1 758)	(2 636)	(3 178)	(2 893)	(2 725)	(3 161)	(3 425)	(3 348)	(3 338)	(1 113)	(1 286)	(1 363)	(1 299)	(686)	(831)	(683)	(729)	(803)	(962)	(1 010)	(1 042)
Research & Development	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(62)	0	0	0	(62)	0	0	0	(58)	0	0	0	(77)	0	0	0	(109)	0	0	(32)	(133)	(60)	(95)	(102)	(119)	(135)	(127)	(109)	(88)	(103)	(92)	(89)	(8)	(38)	(27)	(11)	(7)	(11)	(15)	(19)	(19)	(31)	(37)	(44)	(35)	(46)	(45)	(40)	(43)	(50)	(47)	(52)
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(94)	0	0	0	(131)	0	0	0	(160)	0	0	0	(165)	0	0	0	(232)	0	0	0	(266)	0	0	0	(333)	0	0	0	(445)	0	0	0	(423)	0	0	0	(378)	0	0	0	(226)	0	0	0	(211)	0	0	0	(234)	0	0	0
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	(0)	0	(2)	(2)	(2)	(2)	(3)	(2)	(3)	(3)	(4)	(3)	(1)	(1)	(5)	(6)	(6)	(7)	(10)	(8)	(12)	(20)	(1)	(27)	(22)	(14)	(18)	(9)	(14)	(21)	(17)	(32)	(48)	(52)	(43)	(110)	(104)	(91)	(57)	(57)	(49)	(56)	(30)	(126)	(66)	(54)	(43)	(91)	(99)	(92)	(72)	(1 097)	(1 131)	(1 135)	(83)	(21 838)	(21 814)	(21 811)	(7)	14 410	14 383	14 370	19	(842)	(823)	(817)	21	(159)	(177)	(186)	39	193	197	211
Operating Income	115 N/A	122 +6%	121 -1%	121 0%	120 0%	124 +4%	137 +10%	151 +11%	167 +11%	176 +5%	199 +13%	217 +9%	240 +11%	260 +8%	296 +14%	327 +10%	332 +2%	404 +22%	433 +7%	465 +7%	598 +29%	675 +13%	725 +8%	802 +11%	853 +6%	984 +15%	1 074 +9%	1 195 +11%	1 295 +8%	1 494 +15%	1 650 +10%	1 755 +6%	1 961 +12%	2 166 +10%	2 270 +5%	2 431 +7%	2 477 +2%	2 644 +7%	2 763 +5%	2 909 +5%	3 041 +5%	3 212 +6%	3 356 +4%	3 509 +5%	3 569 +2%	3 834 +7%	4 122 +8%	4 382 +6%	4 579 +5%	4 951 +8%	5 164 +4%	5 455 +6%	3 920 -28%	3 044 -22%	2 438 -20%	1 693 -31%	2 488 +47%	2 435 -2%	2 174 -11%	1 998 -8%	(1 830) N/A	(3 036) -66%	(3 922) -29%	(4 843) -23%	(23 464) -385%	(25 073) -7%	(24 763) +1%	(24 454) +1%	(4 020) +84%	10 906 N/A	10 947 +0%	10 952 +0%	(1 011) N/A	(1 698) -68%	(1 679) +1%	(1 627) +3%	172 N/A	84 -51%	165 +96%	121 -27%	(388) N/A	(58) +85%	(35) +39%	20 N/A
Pre-Tax Income
Interest Income Expense	(11)	(11)	(13)	(14)	(11)	(12)	(12)	(13)	(18)	(21)	(26)	(31)	1	(7)	(12)	(23)	2	(23)	(15)	(1)	(25)	(31)	(40)	(49)	(59)	(72)	(73)	(106)	(147)	(185)	(236)	(261)	(263)	(280)	(284)	(278)	(298)	(331)	(355)	(393)	(375)	(372)	(346)	(333)	(351)	(418)	(507)	(588)	(622)	(731)	(737)	(809)	(1 090)	(1 264)	(1 535)	(1 776)	(1 797)	(1 941)	(2 078)	(2 144)	(2 134)	(1 423)	(1 503)	(1 504)	(2 167)	(2 308)	(1 859)	(1 308)	(1 017)	(370)	(160)	(152)	(39)	(37)	(23)	(13)	(25)	37	30	37	(4)	23	11	14
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(1)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(1)	(2)	56	0	(1)	0	(6)	0	0	(1)	77	(17)	(19)	(18)	(2 019)	(45)	2	2	13 579	62	18	18	(1 028)	21	21	21	(77)	26	28	27	356	14	11	13
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(0)	(1)	(1)	0	(1)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(6)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income	2	2	2	2	0	(0)	2	2	1	0	1	0	10	10	6	6	4	5	8	5	9	10	3	8	39	37	41	38	28	35	29	27	(4)	(7)	11	15	35	38	42	43	41	40	31	34	25	28	26	29	30	37	29	25	(8)	(16)	(6)	(0)	(13)	(20)	(22)	(37)	(504)	(499)	(501)	(497)	(28)	(564)	(564)	(560)	(387)	(1 956)	(1 937)	(2 541)	(587)	(881)	(905)	(300)	41	17	28	77	70	59	52	(2)
Pre-Tax Income	106 N/A	112 +6%	110 -2%	109 -1%	109 +0%	112 +3%	127 +13%	140 +11%	149 +6%	157 +5%	174 +11%	187 +8%	252 +35%	263 +4%	290 +10%	310 +7%	337 +9%	386 +15%	426 +10%	468 +10%	582 +24%	654 +12%	688 +5%	762 +11%	833 +9%	950 +14%	1 042 +10%	1 127 +8%	1 180 +5%	1 344 +14%	1 444 +7%	1 520 +5%	1 693 +11%	1 880 +11%	1 997 +6%	2 168 +9%	2 214 +2%	2 351 +6%	2 450 +4%	2 559 +4%	2 707 +6%	2 880 +6%	3 041 +6%	3 210 +6%	3 243 +1%	3 444 +6%	3 640 +6%	3 822 +5%	3 988 +4%	4 257 +7%	4 455 +5%	4 670 +5%	2 877 -38%	1 765 -39%	897 -49%	(83) N/A	672 N/A	474 -29%	74 -84%	(185) N/A	(4 391) -2 279%	(4 975) -13%	(5 945) -19%	(6 862) -15%	(27 684) -303%	(27 989) -1%	(27 184) +3%	(26 319) +3%	8 155 N/A	8 642 +6%	8 868 +3%	8 277 -7%	(2 664) N/A	(2 595) +3%	(2 587) +0%	(1 920) +26%	110 N/A	164 +49%	251 +53%	262 +5%	35 -87%	38 +9%	38 +2%	46 +20%
Net Income
Tax Provision	(34)	(37)	(36)	(35)	(36)	(37)	(42)	(47)	(50)	(52)	(58)	(62)	(73)	(78)	(80)	(81)	(43)	(44)	(39)	(36)	(80)	(92)	(98)	(110)	(118)	(164)	(200)	(242)	(175)	(173)	(166)	(150)	(251)	(285)	(319)	(345)	(334)	(438)	(488)	(568)	(421)	(367)	(349)	(314)	(486)	(520)	(555)	(587)	(651)	(840)	(733)	(776)	(734)	(434)	(423)	(245)	(302)	(294)	(254)	(243)	(264)	(196)	(216)	(196)	(63)	(58)	(72)	(83)	(235)	(237)	(210)	(215)	(30)	(37)	(37)	(36)	(7)	(2)	(4)	(4)	(23)	(25)	(26)	(27)
Income from Continuing Operations	71	76	74	73	73	75	85	94	100	105	116	125	179	185	210	229	295	343	387	433	502	562	591	652	716	786	842	885	1 005	1 170	1 277	1 371	1 441	1 595	1 678	1 822	1 880	1 914	1 963	1 992	2 286	2 513	2 692	2 896	2 756	2 924	3 085	3 235	3 337	3 417	3 722	3 894	2 144	1 331	474	(327)	370	180	(180)	(427)	(4 655)	(5 171)	(6 161)	(7 058)	(27 747)	(28 047)	(27 256)	(26 402)	7 920	8 405	8 657	8 062	(2 694)	(2 633)	(2 624)	(1 956)	104	162	247	258	12	12	12	19
Income to Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(0)	(0)	0	0	(0)	(0)	(0)	(1)	(0)	(1)	(0)	0	0	0	(1)	0	3	5	6	4	3	4	6	6	10	13	16	4	1	(4)	(10)	(5)	(7)	(9)	(8)	11	10	14	13	(2)	(2)	(5)	(5)	6	5	5	5	(1)	(2)	(3)	(3)	(4)	(3)	(3)	(2)
Net Income (Common)	71 N/A	76 +7%	74 -2%	73 -1%	73 0%	75 +3%	85 +13%	94 +11%	100 +6%	105 +5%	116 +10%	125 +8%	179 +43%	185 +3%	210 +14%	229 +9%	295 +29%	343 +16%	387 +13%	433 +12%	502 +16%	562 +12%	591 +5%	652 +10%	716 +10%	786 +10%	842 +7%	885 +5%	1 005 +14%	1 170 +16%	1 277 +9%	1 371 +7%	1 441 +5%	1 595 +11%	1 678 +5%	1 822 +9%	1 880 +3%	1 913 +2%	1 962 +3%	1 991 +1%	2 286 +15%	2 513 +10%	2 692 +7%	2 895 +8%	2 757 -5%	2 928 +6%	3 090 +6%	3 241 +5%	3 340 +3%	3 419 +2%	3 726 +9%	3 900 +5%	2 150 -45%	1 341 -38%	487 -64%	(312) N/A	374 N/A	182 -51%	(184) N/A	(437) -138%	(4 661) -967%	(5 178) -11%	(6 170) -19%	(7 065) -15%	(27 736) -293%	(28 036) -1%	(27 242) +3%	(26 389) +3%	7 918 N/A	8 403 +6%	8 652 +3%	8 057 -7%	(2 689) N/A	(2 628) +2%	(2 619) +0%	(1 951) +26%	103 N/A	160 +56%	244 +52%	256 +5%	9 -97%	10 +12%	10 +1%	17 +71%
EPS (Diluted)	0.03 N/A	0.04 +33%	0.04 N/A	0.04 N/A	0.03 -25%	0.04 +33%	0.03 -25%	0.03 N/A	0.03 N/A	0.03 N/A	0.04 +33%	0.04 N/A	0.06 +50%	0.05 -17%	0.06 +20%	0.07 +17%	0.08 +14%	0.1 +25%	0.11 +10%	0.12 +9%	0.13 +8%	0.15 +15%	0.16 +7%	0.17 +6%	0.18 +6%	0.19 +6%	0.19 N/A	0.2 +5%	0.23 +15%	0.26 +13%	0.29 +12%	0.31 +7%	0.33 +6%	0.37 +12%	0.39 +5%	0.42 +8%	0.43 +2%	0.43 N/A	0.44 +2%	0.45 +2%	0.52 +16%	0.58 +12%	0.62 +7%	0.66 +6%	0.63 -5%	0.66 +5%	0.56 -15%	0.64 +14%	0.67 +5%	0.69 +3%	0.74 +7%	0.78 +5%	0.39 -50%	0.26 -33%	0.09 -65%	-0.06 N/A	0.08 N/A	0.03 -63%	-0.03 N/A	-0.08 -167%	-0.99 -1 138%	-1.04 -5%	-1.24 -19%	-1.42 -15%	-5.62 -296%	-5.63 0%	-5.14 +9%	-4.98 +3%	0.57 N/A	0.6 +5%	0.61 +2%	0.58 -5%	-0.2 N/A	-0.19 +5%	-0.19 N/A	-0.14 +26%	0.01 N/A	0.01 N/A	0.02 +100%	0.02 N/A	0 N/A	0 N/A	0 N/A	0 N/A

Income Statement Balance Sheet Cash Flow Statement

Kangmei Pharmaceutical Co Ltd
SSE:600518

Income Statement

Earnings Waterfall
Kangmei Pharmaceutical Co Ltd

Income Statement
Kangmei Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Kangmei Pharmaceutical Co Ltd SSE:600518

Income Statement

Earnings Waterfall Kangmei Pharmaceutical Co Ltd

Income Statement Kangmei Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Kangmei Pharmaceutical Co Ltd
SSE:600518

Earnings Waterfall
Kangmei Pharmaceutical Co Ltd

Income Statement
Kangmei Pharmaceutical Co Ltd